At the core of Nutrition 21, lies the belief that high quality science and ground-breaking technology can lead to the development of superior ingredients. The company’s scientific platform is based upon our ability to create patentable ingredients and products that have enhanced absorption and bioavailability to produce safe and clinically efficacious results.

The company’s current product line targets conditions associated with diabetes, obesity, metabolic syndrome, cardiovascular health, arthritis, cognitive health, and immune function. Poor nutrition can contribute to chronic conditions, and Nutrition 21’s ingredients can be used in products that provide consumers with the added nutrition they desire. The Company’s lead ingredients include Chromax chromium picolinate, Diachrome chromium picolinate + biotin, Selenomax high-selenium yeast, Zinmax zinc picolinate and Probiomega probiotic.

Beginning in 1999, Nutrition 21 launched an ambitious research program designed to bring pharmaceutical quality research to develop a better understanding of the beneficial effects of the trace mineral chromium, in the form of Chromax chromium picolinate. Nutrition 21’s research program had uncovered what may represent a fundamentally new appreciation of chromium--and other nutrients such as biotin—and their interrelated roles in complex metabolic and biochemical pathways linking diabetes, cardiovascular health, obesity, depression, and other health conditions. Chromax chromium picolinate is now the leader in the chromium category because of chromium picolinate's enhanced absorption and bioavailability, and the numerous quality clinical studies supporting its safety and efficacy.

Nutrition 21 also has a pipeline of new ingredients that will continue to follow its tradition of science-based technology, providing enhanced absorption and bioavailability, and the highest quality that consumers and health care professionals can be confident in.